Review
Experimental Models for Studying Food Allergy

https://doi.org/10.1016/j.jcmgh.2018.05.010Get rights and content
Under a Creative Commons license
open access

Immunoglobulin E–mediated food allergy is rapidly developing into a global health problem. Publicly available therapeutic intervention strategies are currently restricted to allergen avoidance and emergency treatments. To gain a better understanding of the disease pathophysiology so that new therapies can be developed, major research efforts have been put into studying food allergy in mice. Animal models should reflect the human pathology as closely as possible to allow for a rapid translation of basic science observations to the bedside. In this regard, experimental models of food allergy provide significant challenges for research because of discrepancies between the presentation of disease in humans and mice. The goal of this review is to give a summary of commonly used murine disease models and to discuss how they relate to the human condition. We will focus on epicutaneous sensitization models, on mouse strains that sensitize spontaneously to food as seen in humans, and on models in humanized animals. In summary, expanding the research toolbox of experimental food allergy provides an important step toward closing gaps in our understanding of the derailing immune mechanism that underlies the human disease. The availability of additional experimental models will provide exciting opportunities to discover new intervention points for the treatment of food allergies. (Cell Mol Gastroenterol Hepatol 2018;x:x)

Keywords

Murine Models of Food Allergy
Epictutaneous Sensitization
Spontaneous Sensitization
Humanized Model
FCERIA
IgE
Anaphylaxis
Allergen Sensitization
Allergen Challenge

Abbreviations used in this paper

EPIT
epicutaneous immunotherapy
FCER1A
high-affinity immunoglobulin epsilon receptor subunit alpha
FcεRI
high-affinity immunoglobulin E receptor
GM-CSF
granulocyte-macrophage colony-stimulating factor
HSC
hematopoietic stem cell
Ig
immunoglobulin
IL
interleukin
LCT
long chain triglycerides
MCPT
mouse mast cell protease
MCT
medium chain triglycerides
OIT
oral immunotherapy
PBMC
peripheral blood mononuclear cell
Th
T helper
Treg
regulatory T cell
TSLP
thymic stromal lymphopoietin
WASP
Wiskott–Aldrich syndrome protein

Cited by (0)

Author contributions All authors were involved in the conception, writing, and editing of the manuscript.

Conflicts of interest The authors disclose no conflicts.

Funding The research group is supported by a Bridge Grant from the Research Council of Boston Children’s Hospital, an Emerging Investigator Award from FARE, a Senior Research Award from the Crohn’s and Colitis Foundation, and an unrestricted gift from the Mead Johnson Nutrition Company (all to E.F.). C.K. is supported by a postdoctoral training award from the Fonds de recherche Québec Santé (FRQS).